These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30076962)

  • 1. Glucose-free/high-protein diet improves hepatomegaly and exercise intolerance in glycogen storage disease type III mice.
    Pagliarani S; Lucchiari S; Ulzi G; Ripolone M; Violano R; Fortunato F; Bordoni A; Corti S; Moggio M; Bresolin N; Comi GP
    Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3407-3417. PubMed ID: 30076962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Narrative review of glycogen storage disorder type III with a focus on neuromuscular, cardiac and therapeutic aspects.
    Berling É; Laforêt P; Wahbi K; Labrune P; Petit F; Ronzitti G; O'Brien A
    J Inherit Metab Dis; 2021 May; 44(3):521-533. PubMed ID: 33368379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of GSDIII Phenotype with Gene Transfer Requires Liver- and Muscle-Targeted GDE Expression.
    Vidal P; Pagliarani S; Colella P; Costa Verdera H; Jauze L; Gjorgjieva M; Puzzo F; Marmier S; Collaud F; Simon Sola M; Charles S; Lucchiari S; van Wittenberghe L; Vignaud A; Gjata B; Richard I; Laforet P; Malfatti E; Mithieux G; Rajas F; Comi GP; Ronzitti G; Mingozzi F
    Mol Ther; 2018 Mar; 26(3):890-901. PubMed ID: 29396266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse model of glycogen storage disease type III.
    Liu KM; Wu JY; Chen YT
    Mol Genet Metab; 2014 Apr; 111(4):467-76. PubMed ID: 24613482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep morphological analysis of muscle biopsies from type III glycogenesis (GSDIII), debranching enzyme deficiency, revealed stereotyped vacuolar myopathy and autophagy impairment.
    Laforêt P; Inoue M; Goillot E; Lefeuvre C; Cagin U; Streichenberger N; Leonard-Louis S; Brochier G; Madelaine A; Labasse C; Hedberg-Oldfors C; Krag T; Jauze L; Fabregue J; Labrune P; Milisenda J; Nadaj-Pakleza A; Sacconi S; Mingozzi F; Ronzitti G; Petit F; Schoser B; Oldfors A; Vissing J; Romero NB; Nishino I; Malfatti E
    Acta Neuropathol Commun; 2019 Oct; 7(1):167. PubMed ID: 31661040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III.
    Francini-Pesenti F; Tresso S; Vitturi N
    Acta Myol; 2019 Mar; 38(1):17-20. PubMed ID: 31309177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercise intolerance in Glycogen Storage Disease Type III: weakness or energy deficiency?
    Preisler N; Pradel A; Husu E; Madsen KL; Becquemin MH; Mollet A; Labrune P; Petit F; Hogrel JY; Jardel C; Maillot F; Vissing J; Laforêt P
    Mol Genet Metab; 2013 May; 109(1):14-20. PubMed ID: 23507172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis.
    Melis D; Rossi A; Pivonello R; Del Puente A; Pivonello C; Cangemi G; Negri M; Colao A; Andria G; Parenti G
    Bone; 2016 May; 86():79-85. PubMed ID: 26924264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural Progression of Canine Glycogen Storage Disease Type IIIa.
    Brooks ED; Yi H; Austin SL; Thurberg BL; Young SP; Fyfe JC; Kishnani PS; Sun B
    Comp Med; 2016 Feb; 66(1):41-51. PubMed ID: 26884409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial Effects of Modified Atkins Diet in Glycogen Storage Disease Type IIIa.
    Olgac A; İnci A; Okur İ; Biberoğlu G; Oğuz D; Ezgü FS; Kasapkara ÇS; Aktaş E; Tümer L
    Ann Nutr Metab; 2020; 76(4):233-241. PubMed ID: 32712609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skeletal muscle metabolism is impaired during exercise in glycogen storage disease type III.
    Preisler N; Laforêt P; Madsen KL; Prahm KP; Hedermann G; Vissing CR; Galbo H; Vissing J
    Neurology; 2015 Apr; 84(17):1767-71. PubMed ID: 25832663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrition therapy for hepatic glycogen storage diseases.
    Goldberg T; Slonim AE
    J Am Diet Assoc; 1993 Dec; 93(12):1423-30. PubMed ID: 8245377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome.
    Sentner CP; Hoogeveen IJ; Weinstein DA; Santer R; Murphy E; McKiernan PJ; Steuerwald U; Beauchamp NJ; Taybert J; Laforêt P; Petit FM; Hubert A; Labrune P; Smit GPA; Derks TGJ
    J Inherit Metab Dis; 2016 Sep; 39(5):697-704. PubMed ID: 27106217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen storage disease type III: A novel Agl knockout mouse model.
    Pagliarani S; Lucchiari S; Ulzi G; Violano R; Ripolone M; Bordoni A; Nizzardo M; Gatti S; Corti S; Moggio M; Bresolin N; Comi GP
    Biochim Biophys Acta; 2014 Nov; 1842(11):2318-28. PubMed ID: 25092169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.
    Decostre V; Laforêt P; De Antonio M; Kachetel K; Canal A; Ollivier G; Nadaj-Pakleza A; Petit FM; Wahbi K; Fayssoil A; Eymard B; Behin A; Labrune P; Hogrel JY
    Mol Genet Metab; 2017 Nov; 122(3):108-116. PubMed ID: 28888851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diet therapy in severe clinical expression of debrancher deficiency.
    Azael Meza A; Ayub M; Cantú JM; Flores J
    Arch Invest Med (Mex); 1991; 22(3-4):285-8. PubMed ID: 1844114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet.
    Dagli AI; Zori RT; McCune H; Ivsic T; Maisenbacher MK; Weinstein DA
    J Inherit Metab Dis; 2009 Dec; 32 Suppl 1(0 1):S103-6. PubMed ID: 19322675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage disease type III: modified Atkins diet improves myopathy.
    Mayorandan S; Meyer U; Hartmann H; Das AM
    Orphanet J Rare Dis; 2014 Nov; 9():196. PubMed ID: 25431232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of glycogen storage disease type IIIA by detecting glycogen debranching enzyme activity, glycogen content and structure in muscle].
    Wang W; We M; Song HM; Qiu ZQ; Zhang WM; Wu XY; Lu CX; Qi JM; Jing H; Li F
    Zhonghua Er Ke Za Zhi; 2009 Aug; 47(8):608-12. PubMed ID: 19951495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of severe cardiomyopathy in glycogen storage disease type III With D,L-3-hydroxybutyrate, ketogenic and high-protein diet.
    Valayannopoulos V; Bajolle F; Arnoux JB; Dubois S; Sannier N; Baussan C; Petit F; Labrune P; Rabier D; Ottolenghi C; Vassault A; Broissand C; Bonnet D; de Lonlay P
    Pediatr Res; 2011 Dec; 70(6):638-41. PubMed ID: 21857385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.